167 related articles for article (PubMed ID: 28755573)
1. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
[TBL] [Abstract][Full Text] [Related]
2. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
3. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
[TBL] [Abstract][Full Text] [Related]
4. Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of
Scalese G; Machado I; Salinas G; Pérez-Díaz L; Gambino D
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500808
[TBL] [Abstract][Full Text] [Related]
5. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
6. Oxidovanadium(IV) and dioxidovanadium(V) complexes of tridentate salicylaldehyde semicarbazones: searching for prospective antitrypanosomal agents.
Fernández M; Becco L; Correia I; Benítez J; Piro OE; Echeverria GA; Medeiros A; Comini M; Lavaggi ML; González M; Cerecetto H; Moreno V; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2013 Oct; 127():150-60. PubMed ID: 23528424
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium(IV) complexes of salicylaldimines and polypyridyl ligands.
Scalese G; Correia I; Benítez J; Rostán S; Marques F; Mendes F; Matos AP; Costa Pessoa J; Gambino D
J Inorg Biochem; 2017 Jan; 166():162-172. PubMed ID: 27865131
[TBL] [Abstract][Full Text] [Related]
8. A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent.
Benítez J; Guggeri L; Tomaz I; Pessoa JC; Moreno V; Lorenzo J; Avilés FX; Garat B; Gambino D
J Inorg Biochem; 2009 Oct; 103(10):1386-94. PubMed ID: 19695708
[TBL] [Abstract][Full Text] [Related]
9. Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi.
Rodríguez Arce E; Machado I; Rodríguez B; Lapier M; Zúñiga MC; Maya JD; Olea Azar C; Otero L; Gambino D
J Inorg Biochem; 2017 May; 170():125-133. PubMed ID: 28237731
[TBL] [Abstract][Full Text] [Related]
10. Development of new dinuclear Fe(III) coordination compounds with
Moreira FF; Portes JA; Barros Azeredo NF; Fernandes C; Horn A; Santiago CP; Segat BB; Caramori GF; Madureira LMP; Candela DRS; Marques MM; Lamounier Camargos Resende JA; de Souza W; DaMatta RA; Seabra SH
Dalton Trans; 2021 Sep; 50(35):12242-12264. PubMed ID: 34519725
[TBL] [Abstract][Full Text] [Related]
11. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
[TBL] [Abstract][Full Text] [Related]
12. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
13. Multi-target heteroleptic palladium bisphosphonate complexes.
Cipriani M; Rostán S; León I; Li ZH; Gancheff JS; Kemmerling U; Olea Azar C; Etcheverry S; Docampo R; Gambino D; Otero L
J Biol Inorg Chem; 2020 May; 25(3):509-519. PubMed ID: 32232584
[TBL] [Abstract][Full Text] [Related]
14. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex.
Paixão DA; Lopes CD; Carneiro ZA; Sousa LM; de Oliveira LP; Lopes NP; Pivatto M; Chaves JDS; de Almeida MV; Ellena J; Moreira MB; Netto AVG; de Oliveira RJ; Guilardi S; de Albuquerque S; Guerra W
Biomed Pharmacother; 2019 Jan; 109():157-166. PubMed ID: 30396072
[TBL] [Abstract][Full Text] [Related]
15. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
[TBL] [Abstract][Full Text] [Related]
16. Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.
Álvarez G; Perdomo C; Coronel C; Aguilera E; Varela J; Aparicio G; Zolessi FR; Cabrera N; Vega C; Rolón M; Rojas de Arias A; Pérez-Montfort R; Cerecetto H; González M
Molecules; 2017 May; 22(5):. PubMed ID: 28481276
[TBL] [Abstract][Full Text] [Related]
17. Design of vanadium mixed-ligand complexes as potential anti-protozoa agents.
Benítez J; Guggeri L; Tomaz I; Arrambide G; Navarro M; Pessoa JC; Garat B; Gambino D
J Inorg Biochem; 2009 Apr; 103(4):609-16. PubMed ID: 19091422
[TBL] [Abstract][Full Text] [Related]
18. New uses for old complexes: The very first report on the trypanocidal activity of symmetric trinuclear ruthenium complexes.
Possato B; Carneiro ZA; de Albuquerque S; Nikolaou S
J Inorg Biochem; 2017 Nov; 176():156-158. PubMed ID: 28915432
[TBL] [Abstract][Full Text] [Related]
19. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases.
Cunha Almeida T; Gonzaga Ribeiro LH; Ferreira Dos Santos LB; da Silva CM; Tupinambá Branquinho R; de Lana M; Ramos Gadelha F; de Fátima Â
Biomed Pharmacother; 2018 Dec; 108():1703-1711. PubMed ID: 30372873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
